1. Baune A, Glatting G, Karitzky J, Sommer FT. Dynamische Clusteranalyse von C-11-PK11195 PET Daten des Gehirns. In:Bildverarbeitung in der Medizin: Springer, 2002; 259-262.
  2. Braun V, Dempf S, Weller R, Reske SN, Schachenmayr W, Richter HP. Cranial neuronavigation with direct integration of 11C methionine positron emission tomography (PET) data -- results of a pilot study in 32 surgical cases. Acta Neurochir (Wien) 2002; 144:777-782.
  3. Brix G, Nosske D, Glatting G, Minkov V, Reske SN. A survey of PET activity in Germany during 1999. Eur J Nucl Med Mol Imaging 2002; 29:1091-1097.
  4. Buchmann I, Bunjes D, Kotzerke J, Martin H, Glatting G, Seitz U, Rattat D, Buck A, Dohner H, Reske SN. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities. Cancer Biother Radiopharm 2002; 17:151-163.
  5. Buck AC, Shen C, Schirrmeister H, Schmid-Kotsas A, Munzert G, Guhlmann A, Mehrke G, Klug N, Gross HJ, Bachem M, Reske SN. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis. Cancer Biother Radiopharm 2002; 17:281-289.
  6. Buck AK, Schirrmeister H, Hetzel M, Von Der Heide M, Halter G, Glatting G, Mattfeldt T, Liewald F, Reske SN, Neumaier B. 3-deoxy-3-[18F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res 2002; 62:3331-3334.
  7. Buck AK, Schirrmeister H, Kuhn T, Shen C, Kalker T, Kotzerke J, Dankerl A, Glatting G, Reske S, Mattfeldt T. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging 2002; 29:1317-1323.
  8. Bunjes D, Buchmann I, Duncker C, Seitz U, Kotzerke J, Wiesneth M, Dohr D, Stefanic M, Buck A, von Harsdorf S, Glatting G, Grimminger W, Schlenk R, Munzert G, Döhner H, Bergmann L, Reske SN. Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an 188Re-Labelled anti-CD66 Monoclonal Antibody. In:Transplantation in Hematology and Oncology II. Berlin, Heidelberg, New York: Springer-Verlag, 2002; 43-58.
  9. Fenchel S, Grab D, Nuessle K, Kotzerke J, Rieber A, Kreienberg R, Brambs HJ, Reske SN. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002; 223:780-788.
  10. Seitz U, Wagner M, Neumaier B, Wawra E, Glatting G, Leder G, Schmid RM, Reske SN. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines. Eur J Nucl Med Mol Imaging 2002; 29:1174-1181.
  11. Kotzerke J, Volkmer BG, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2002; 29:1380-1394.
  12. Landmann M, Reske SN, Glatting G. Simultaneous iterative reconstruction of emission and attenuation images in positron emission tomography from emission data only. Med Phys 2002; 29:1962-1967.
  13. Rieber A, Schirrmeister H, Gabelmann A, Nuessle K, Reske S, Kreienberg R, Brambs HJ, Kuehn T. Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? Br J Radiol 2002; 75:789-798.
  14. Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 2002; 29:361-366.
  15. Zurowski B, Gostomzyk J, Gron G, Weller R, Schirrmeister H, Neumeier B, Spitzer M, Reske SN, Walter H. Dissociating a common working memory network from different neural substrates of phonological and spatial stimulus processing. Neuroimage 2002; 15:45-57.